Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

INTRODUCTION: Maintaining fluid intake sufficient to reduce arginine vasopressin (AVP) secretion has been hypothesised to slow kidney cyst growth in autosomal dominant polycystic kidney disease (ADPKD). However, evidence to support this as a clinical practice recommendation is of poor quality. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Annette T Y, Mannix, Carly, Grantham, Jared J, Allman-Farinelli, Margaret, Badve, Sunil V, Boudville, Neil, Byth, Karen, Chan, Jessie, Coulshed, Susan, Edwards, Marie E, Erickson, Bradley J, Fernando, Mangalee, Foster, Sheryl, Haloob, Imad, Harris, David C H, Hawley, Carmel M, Hill, Julie, Howard, Kirsten, Howell, Martin, Jiang, Simon H, Johnson, David W, Kline, Timothy L, Kumar, Karthik, Lee, Vincent W, Lonergan, Maureen, Mai, Jun, McCloud, Philip, Peduto, Anthony, Rangan, Anna, Roger, Simon D, Sud, Kamal, Torres, Vincent, Vliayuri, Eswari, Rangan, Gopala K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780847/
https://www.ncbi.nlm.nih.gov/pubmed/29358433
http://dx.doi.org/10.1136/bmjopen-2017-018794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780847/
https://www.ncbi.nlm.nih.gov/pubmed/29358433
http://dx.doi.org/10.1136/bmjopen-2017-018794

Ejemplares similares